Treatment News : HIV Causes AIDS by 'Cellular Suicide,' Not 'Viral Murder'

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » December 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

December 20, 2013

HIV Causes AIDS by 'Cellular Suicide,' Not 'Viral Murder'

Defining for the first time exactly how HIV causes AIDS, scientists have found that, without treatment, the virus successfully spurs the immune system into a suicidal overdrive, MedPage Today reports. While the virus initiates this effective death spiral, the primary driver of the damage to the immune system is actually the immune response itself. Researchers at the Gladstone Institutes, which is affiliated with the University of California, San Francisco, have published two simultaneous papers, in Nature and in Science, on their discoveries.  

“Our studies have investigated and identified the root cause of AIDS—how CD4 T cells die,” Gladstone staff research investigator Gilad Doitsh, PhD, who is one of the Nature paper’s lead author, said in a release. “Despite some 30 years of HIV research, this key HIV/AIDS process has remained pretty much a black box.”

The process is "much more of a cellular suicide than a viral murder," according to Warner Greene, MD, PhD, of the Gladstone Institutes and the University of California San Francisco.

The investigators have also found an existing anti-inflammatory drug that blocks the death of immune cells; they’re hoping for a Phase II clinical trial with the drug in the near future.

Ninety-five percent of a person’s CD4 cells are in a resting state at any given time, and therefore HIV cannot infect them. But the virus can still lead to these cells’ death through this immune response, the mechanics of which are now more completely understood. After HIV attempts and fails to infect a resting CD4 cell—this is called an abortive infection—particles of the virus remain in the cell and are detected by a protein called IFI16. This protein then activates the human enzyme caspase-1, leading to a highly inflammatory death known as pyroptosis.

The Nature paper shows that this inflammatory process attracts more CD4 cells to the site, which in these tissue studies led to to the cycle of more abortive infection, cell death, inflammation and the recruitment of further CD4s. Thus, in humans, the immune system would eventually be depleted and the host would be vulnerable to AIDS-defining illnesses. When HIV infects active CD4 cells, this dramatic process does not occur; the cells eventually die in a quieter process called apoptosis, without attracting all the extra immune response.

The researchers found that, in tissue experiments, inhibiting caspase-1 with a drug known as VX-765, a Vertex-owned compound which Phase IIb clinical trials have found safe and effective for the treatment of epilepsy and psoriasis, both prevents the death of the abortively infected resting CD4s and prevents the resulting inflammatory response.  

If the drug proves effective in the hoped-for trials and is one day cheap and widely available, it might serve as a means to slow the progression to AIDS for people with HIV around the world who are waiting for access to antiretroviral (ARV) treatment. The drug might also serve as an adjunct to ARVs.
 
Also, because inflammation leads the body to generate cytokines that then spur the development of memory T cells, which are a part of the viral reservoir, a caspase-1 inhibitor might become a component of a multi-pronged HIV cure approach that slowly depletes the reservoir.

To read the MedPage Today story, click here.

To read the Gladstone Institutes press release, click here.

To read the Science abstract, click here.

Search: HIV, AIDS, cellular suicide, viral murder, Gladstone Institutes, University of California, San Francisco, Gilad Doitsh, Warner Greene, resting CD4 cells, caspase-1, pyroptosis, Nature, Science, apoptosis, VX-765, Vertex, reservoir.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    chrisf
    san jose
    California


    koffeeboss
    Tucson
    Arizona


    Heartland4now
    Tacoma
    Washington


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.